status retinol, karotenoid dan tokoferol pemakai kontrasepsi implan dan suntikan dengan komplikasi pendarahan

Clicks: 184
ID: 130973
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract

The case study of Status of Retinol Carotenoid and Tocopherol of Implant and Injection Contraseptive Users with Bleeding Complication conducted in 3 health centers in Bogor. The total number of the subjects were 68 women who used implant contraseptive (39 were as control and 29 were as cases) and 59 women who used injection (31 were as control and 28 were as cases). The results showed were as that prevalence of anemia were 25% in injection case and 27.6% in implant case. The average of serum retinol, carotenoids and tocopherol were not significantly different between injection case and control. While the implant users were significantly different between case and control in term of serum alfa tocopherol (19.3 + 3.1 vs 13.7 + 3.04). The odd ratio for injection contraseptive ussers was 1.55 for lutein; while for implant contraseptive users was 2.49 for alfa carotene, 5.89 for alfa tocopherol and 1.39 for gamma tocopherol.

Keywords: retinol, carotenooids, tocopherol, contraseptive users

Reference Key
miawati2012penelitianstatus Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Tita Miawati;Yuniar R. Purwono;Susilowati Herman
Journal penelitian gizi dan makanan
Year 2012
DOI
10.22435/pgm.v0i0.1536.
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.